Evidence map›Paper›PMID 40592879›Full record

ArticleNature communications2025

BAHCC1 binds H4K20me1 to facilitate the MCM complex loading and DNA replication.

Dongxu Li, Zhi-Min Zhang, Liu Mei, Yao Yu, Yiran Guo, Samuel G Mackintosh, Jianbin Chen, David F Allison, Arum Kim, Aaron J Storey and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dongxu Li *Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Zhi-Min Zhang *Department of Biochemistry, University of California, Riverside, Riverside, CA, 92521, USA.
Liu Mei *Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Yao YuDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Yiran GuoDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Samuel G MackintoshDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Jianbin ChenDepartment of Biochemistry, University of California, Riverside, Riverside, CA, 92521, USA.
David F AllisonDepartment of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Arum KimDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Aaron J StoreyDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Ricky D EdmondsonDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Stephanie D ByrumDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.ORCID http://orcid.org/0000-0002-1783-3610
Alan J TackettDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Ling CaiDepartment of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.
Jeanette G CookDepartment of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. jean_cook@med.unc.edu.ORCID http://orcid.org/0000-0003-0849-7405
Jikui SongDepartment of Biochemistry, University of California, Riverside, Riverside, CA, 92521, USA. jikuis@ucr.edu.
Gang Greg WangDepartment of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. greg.wang@duke.edu.ORCID http://orcid.org/0000-0002-7210-9940

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Alan Tackett · 2017 to 2026
$27.6M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
Mechanistic Insights into Mammalian DNA MethylationR35GM119721 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Jikui Song · 2016 to 2026
$5.3M
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in canerR01CA268519 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jian Jin, G Greg Wang · 2022 to 2026
$3.2M
The role for phase separation in oncogenesis and aberrant chromatin looping formationR01CA271603 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Douglas H. Phanstiel, G Greg Wang · 2022 to 2026
$2.9M
Cell Cycle Dynamics that Ensure Genome MaintenanceR35GM141833 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN · 2021 to 2025
$2.8M
The Role of YY1 in Castration-Resistant Prostate CancerR01CA262903 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CAI, LING · 2021 to 2025
$2.1M
Identification of Druggable Targets to Complement Melanoma TherapyR01CA236209 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN · 2019 to 2023
$1.7M
Determining the Role of DNA Methylation Deregulation in OncogenesisR01CA215284 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, G GREG · 2017 to 2021
$1.7M
Intravital point-scanning confocal microscopeS10RR027867 · NCRR · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2010 to 2010
$500k
NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA215284NCI NIH HHS R01 CA236209NCI NIH HHS R01 CA262903NCI NIH HHS R01 CA268519NCI NIH HHS R01 CA271603NCRR NIH HHS S10 RR027867NIGMS NIH HHS P20 GM121293NIGMS NIH HHS R24 GM137786NIGMS NIH HHS R35 GM119721NIGMS NIH HHS R35 GM141833
6 · The paper itself

Abstract

Mono-methylation of histone H4 lysine 20 (H4K20me1) regulates DNA replication, cell cycle progression and DNA damage repair. How exactly H4K20me1 regulates these biological processes remains unclear. Here, we report that an evolutionarily conserved tandem Tudor domain (TTD) in BAHCC1 (BAHCC1

Indexed as

DNA ReplicationHistonesMinichromosome Maintenance ProteinsHEK293 CellsHeLa CellsHumansLysineMethylationOrigin Recognition ComplexProtein BindingReplication OriginHistonesLysineMinichromosome Maintenance ProteinsOrigin Recognition Complex

Identifiers

PMID40592879
PMCPMC12219854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.